UMass Memorial Health

Viracta Therapeutics to Present Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial at the 2024 Annual Congress of The Hematology Society of Taiwan

Retrieved on: 
Monday, April 1, 2024

SAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced that topline results from Stage 1 of the NAVAL-1 trial of Nana-val (nanatinostat in combination with valganciclovir) in patients with relapsed or refractory (R/R) Epstein-Barr virus-positive (EBV+) peripheral T-cell lymphoma (PTCL) will be featured in an oral presentation during the 2024 Joint Annual Congress of Taiwan Society of Blood and Marrow Transplantation and The Hematology Society of Taiwan.

Key Points: 
  • SAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced that topline results from Stage 1 of the NAVAL-1 trial of Nana-val (nanatinostat in combination with valganciclovir) in patients with relapsed or refractory (R/R) Epstein-Barr virus-positive (EBV+) peripheral T-cell lymphoma (PTCL) will be featured in an oral presentation during the 2024 Joint Annual Congress of Taiwan Society of Blood and Marrow Transplantation and The Hematology Society of Taiwan.
  • Details of the presentation are as follows:
    Presenting Author: Professor Hung Chang, M.D., principal investigator in the NAVAL-1 trial, Chief of the Hematology Division, Linkou Chang Gung Memorial Hospital and Visiting Scholar at UMass Memorial Health Care

New Study Finds AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration and Significantly Reduce False Alarms for Clinicians

Retrieved on: 
Tuesday, April 9, 2024

The prediction models used in the study are a part of CLEW’s intelligent clinical surveillance platform.

Key Points: 
  • The prediction models used in the study are a part of CLEW’s intelligent clinical surveillance platform.
  • It also supports the health system with capacity management, by providing early identification of potential bottlenecks caused by unexpected deterioration.
  • In addition to demonstrating its superior accuracy, the study concluded that the CLEW system generated 50-times fewer alarms than other leading systems.
  • In busy and overburdened critical care environments, this can greatly reduce alarm fatigue and the associated cognitive burden on caregivers.

Wolters Kluwer strengthens Clinical GenAI market leadership with AI Labs powered by UpToDate

Retrieved on: 
Monday, March 11, 2024

Wolters Kluwer Health today announced several key milestones for AI Labs, the Clinical Generative AI (GenAI) beta launched in 2023 and powered by UpToDate®, the globally trusted clinical decision support (CDS) solution.

Key Points: 
  • Wolters Kluwer Health today announced several key milestones for AI Labs, the Clinical Generative AI (GenAI) beta launched in 2023 and powered by UpToDate®, the globally trusted clinical decision support (CDS) solution.
  • AI Labs now has access to the complete set of UpToDate’s evidence-based clinical content and graded recommendations across more than 25 medical specialties.
  • “Wolters Kluwer is focused on setting the standard for Clinical GenAI a transformative solution that creates an interactive experience for clinicians and care teams.
  • AI Labs will be demonstrated at the Wolters Kluwer booth, #2927, at the HIMSS24 Global Conference and Exhibition .

UMass Memorial Health Expands Use of Get Well Platform for Social Determinants of Health (SDOH) Screening and Navigation

Retrieved on: 
Tuesday, March 12, 2024

BETHESDA, Md., March 12, 2024 /PRNewswire/ -- Get Well, the global leader in consumer digital patient engagement, today announced that UMass Memorial Health will implement Get Well's Health Equity Social Determinants of Health (SDOH) Screening Solution across the organization. As part of the Get Well 360 platform, the Get Well Health Equity SDOH Screening Solution captures patients' SDOH needs, integrates the data into Electronic Health Records (EHRs), and navigates patients to appropriate resources and community-based organizations (CBOs).

Key Points: 
  • In response, Get Well announced in 2023 the rollout of a health equity solution, which includes SDOH screening and navigation.
  • UMass Memorial Health, Central Massachusetts' largest not-for-profit health care system, will use Get Well's SDOH Screening and Navigation Solution to support care for their more than 50,000 patients in the hospital and 300,000 in outpatient care.
  • "We're incredibly excited to deepen our partnership with UMass Memorial Health," said Michael O'Neil, CEO of Get Well.
  • Get Well Community Navigators will monitor the texts for any questions or needs and connect them with resources such as FindHelp or route them to UMass Memorial Health social workers.

UMass Memorial Health Partners with Google Cloud to Improve Healthcare with Predictive Analytics for Advanced Cardiometabolic Therapies

Retrieved on: 
Wednesday, March 6, 2024

Identifying and treating patients for advanced cardiometabolic therapies can improve healthcare outcomes and reduce the burden of these chronic conditions on patients.

Key Points: 
  • Identifying and treating patients for advanced cardiometabolic therapies can improve healthcare outcomes and reduce the burden of these chronic conditions on patients.
  • This partnership will leverage the power of data and predictive analytics to transform the way healthcare providers deliver personalized care.
  • Key highlights include:
    Advanced Predictive Analytics: UMass Memorial Health is developing advanced predictive analytics models to enable it to analyze vast datasets, including patient health records, clinical data, and biometric information, to identify individuals who are suitable candidates for advanced cardiometabolic therapies.
  • Google Cloud and UMass Memorial Health are committed to ensuring patient privacy and data security.

UMass Memorial Health Integrates LanguageLine App into Epic EHR

Retrieved on: 
Wednesday, February 21, 2024

WORCESTER, Mass., Feb. 21, 2024 /PRNewswire/ -- UMass Memorial Health (UMMH), the largest not-for-profit health system in Central Massachusetts, has become first health system to integrate the LanguageLine Solutions interpreting app into its Epic Electronic Health Record (EHR).

Key Points: 
  • WORCESTER, Mass., Feb. 21, 2024 /PRNewswire/ -- UMass Memorial Health (UMMH), the largest not-for-profit health system in Central Massachusetts, has become first health system to integrate the LanguageLine Solutions interpreting app into its Epic Electronic Health Record (EHR).
  • Integrating into Epic allows sessions to be encrypted and documented in the EHR, delivering a timely, accurate record of the patient's interpretation history.
  • "The Epic integration is a testament to the power of partnership," LanguageLine President and CEO Scott W. Klein said.
  • The LanguageLine app uses the secure healthcare standard SMART on FHIR that ensures patient safety and organizational compliance.

Caregility Helps Transform Inpatient Care with New AI-Enhanced Telehealth Systems

Retrieved on: 
Thursday, January 11, 2024

In a significant leap forward for inpatient care, Caregility is proud to introduce a new class of adaptive telehealth edge devices designed to seamlessly support hybrid care models that bring remote clinicians and artificial intelligence (AI) capabilities into bedside workflows at the point of care.

Key Points: 
  • In a significant leap forward for inpatient care, Caregility is proud to introduce a new class of adaptive telehealth edge devices designed to seamlessly support hybrid care models that bring remote clinicians and artificial intelligence (AI) capabilities into bedside workflows at the point of care.
  • The devices integrate with the award-winning Caregility Cloud™ virtual care platform to enable a multitude of clinical applications.
  • The AI-enhanced telehealth edge devices facilitate seamless virtual clinical interactions, enhancing the efficiency and quality of patient care and clinical team collaboration.
  • Every Caregility device is self-healing, proactively monitored, and remotely managed to ensure reliability and minimize disruption to patient care.

Massachusetts Nurses Association Statement Regarding Healey-Driscoll Administration Reports on Maternal Child Health Access

Retrieved on: 
Thursday, November 16, 2023

CANTON, Mass., Nov. 16, 2023 /PRNewswire/ -- The Massachusetts Nurses Association (MNA) is hereby submitting its response to two reports released today by the Healey administration addressing the issue of maternal child health access: one addressing access to labor, delivery and postpartum care statewide; and the other addressing similar issues for Northern Worcester County following the controversial, and widely opposed closure of the Birthing Center at Leominster Hospital, the 11th such closure in the last decade. 

Key Points: 
  • We are encouraged to see recommendations for a thorough review of access in Northern Worcester County, but believe this should be extended to all regions of the state that have lost access to inpatient maternal health services.
  • The MNA has already filed legislation (S.1450/H.2251) that would establish such a process, but the DPH and the administration can implement this process without legislative action right now.
  • The problem of access to maternal child health services is multifaceted, and we agree that increased reimbursement for these services is necessary, and for some providers serving marginalized communities, funding support from the state may be warranted.
  • Founded in 1903, the Massachusetts Nurses Association is the largest union of registered nurses in the Commonwealth of Massachusetts.

Hastily Arranged "Listening Sessions" on Access to Essential Maternity Services by the Healey-Driscoll Administration Scheduled for Tonight and Next Week

Retrieved on: 
Friday, October 20, 2023

LEOMINSTER, Mass., Oct. 20, 2023 /PRNewswire/ -- The Massachusetts Nurses Association is issuing this statement so that the public is aware of a series of so called "listening sessions" the Governor's office has scheduled for tonight and next week on the issue of access to essential maternal child health services. The notice of all these sessions was just advertised by the state less than 24 hours ago, as we are heading into a weekend with no advertising to the general public, and no concerted outreach to existing community coalitions, advocates or legislators who have been actively involved in efforts to address the loss of 11 maternity programs in recent years, each of which have already been deemed essential by the Department of Public Health to preserving access to maternity services in those communities. The full list of sessions can be found here.

Key Points: 
  • "We are extremely disappointed that the Administration has provided such short notice to participants regarding the Maternal Health Listening Sessions.
  • This is not a process designed to gather substantive feedback," said Katie Murphy, president of the Massachusetts Nurses Association.
  • In each case, the state's Department of Public Health deemed the maternal health services "services are necessary for preserving access and health status within the service area."
  • There are several bills filed with the legislature to address the flawed essential services process:
    We strongly encourage the Healey-Driscoll Administration to look at a comprehensive overhaul of the essential services process with an eye towards preserving services.

Nonprofit Organization Children's Miracle Network Hospitals Announces New CEO

Retrieved on: 
Monday, August 21, 2023

SALT LAKE CITY, Aug. 21, 2023 /PRNewswire-PRWeb/ -- Children's Miracle Network Hospitals, a national nonprofit aimed at raising funds and awareness for local children's hospitals, today announced Aimee Daily, Ph.D., as its next president and CEO, effective Nov. 1. The current president and CEO, Teri Nestel, is retiring after a 40-year career in philanthropy.

Key Points: 
  • Accomplished healthcare executive Aimee Daily, Ph.D., to lead the organization into a new era of fundraising for children's hospitals
    SALT LAKE CITY, Aug. 21, 2023 /PRNewswire-PRWeb/ -- Children's Miracle Network Hospitals , a national nonprofit aimed at raising funds and awareness for local children's hospitals, today announced Aimee Daily, Ph.D., as its next president and CEO, effective Nov. 1.
  • "We are thrilled to welcome Aimee to Children's Miracle Network Hospitals," said Barbara Joers, Children's Miracle Network Hospital's Board Chair and president and CEO of Gillette Children's in St. Paul, Minn. "Aimee's energy, intellectual curiosity and strategic acumen will guide us into a new era of raising critical funds to fulfill the most urgent needs of our member children's hospitals.
  • She was key in developing relationships and leading innovation, both critical components of Children's Miracle Network Hospitals' core work and values.
  • "I'm honored to serve as the next president and CEO of Children's Miracle Network Hospitals," Daily said.